Next Biometrics Group ASA (OSTO:NEXTO) 1-Year Sharpe Ratio: -1.62 (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NEXTO Next Biometrics Group ASA OSTO:NEXTO
32 GF Score
Price kr9.64
GF Value kr79.40
! 6 Warning Signs
View Full Analysis

What is Next Biometrics Group ASA 1-Year Sharpe Ratio?

Next Biometrics Group ASA OSTO:NEXTO 32 1-Year Sharpe Ratio is -1.62 as of Aug. 13, 2026. GuruFocus rates OSTO:NEXTO with a GF Score™ of 32/100 and a GF Value™ of kr79.40. The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-13), Next Biometrics Group ASA's 1-Year Sharpe Ratio is -1.62.


Next Biometrics Group ASA  (OSTO:NEXTo) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Next Biometrics Group ASA 1-Year Sharpe Ratio Related Terms


OSTO:NEXTO vs COHR, KEYS, GRMN: 1-Year Sharpe Ratio Comparison

For the Scientific & Technical Instruments subindustry, Next Biometrics Group ASA's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Biometrics Group ASA 1-Year Sharpe Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Next Biometrics Group ASA's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Next Biometrics Group ASA's 1-Year Sharpe Ratio falls into.


OSTO:NEXTO
32GF Score
Next Biometrics Group ASA OSTO:NEXTO
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Next Biometrics Group ASA 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.62 mean?
Next Biometrics Group ASA (OSTO:NEXTO) has a 1-Year Sharpe Ratio of -1.62 as of Aug. 13, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Next Biometrics Group ASA and its competitors.
Is Next Biometrics Group ASA's 1-Year Sharpe Ratio too high?
Next Biometrics Group ASA's current 1-Year Sharpe Ratio is -1.62. Overall, Next Biometrics Group ASA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Next Biometrics Group ASA's 1-Year Sharpe Ratio compare to COHR and KEYS?
Next Biometrics Group ASA's 1-Year Sharpe Ratio of -1.62 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Hardware company?
A good 1-Year Sharpe Ratio depends on the Hardware industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Next Biometrics Group ASA and its competitors. Next Biometrics Group ASA's current 1-Year Sharpe Ratio is -1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Next Biometrics Group ASA stock overvalued right now?
Next Biometrics Group ASA (OSTO:NEXTO) has a current 1-Year Sharpe Ratio of -1.62. The stock's GF Value™ is kr79.40, compared to a current price of kr9.64 — trading 87.9% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.62. Next Biometrics Group ASA's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Next Biometrics Group ASA (OSTO:NEXTO), the current 1-Year Sharpe Ratio is -1.62 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Next Biometrics Group ASA (OSTO:NEXTO) Overvalued in 2026?

Based on GuruFocus' analysis, Next Biometrics Group ASA stock appears to be undervalued. The current stock price of kr9.64 is trading 87.9% below its estimated GF Value™ of kr79.40.

Key valuation signals for OSTO:NEXTO:

  • 1-Year Sharpe Ratio: -1.62
  • GF Value™: kr79.40 vs. price of kr9.64 (87.9% below fair value)
  • GF Score™: 32/100 with 6 warning signs

No single metric tells the full story. See the OSTO:NEXTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Next Biometrics Group ASA Business Description

Other Exchanges NEXT:Norway0QWK:UK
Address Stortorvet 7, Oslo, NOR, 0155
Next Biometrics Group ASA provides fingerprint sensor technology and products. The company's products are utilized for Smart Card, Government ID, Access control, Notebook, and others. The company's products include smart card solutions, fingerprint sensor modules, fingerprint readers, Aadhar products, Software DevKits, and Hardware DevKits. The company has one operating segment namely; Fingerprint sensor Technology. The company's Geographic customer base consists of Asia (Japan and India), Europe (France and Germany) and North America.
32GF Score

Get the complete analysis for OSTO:NEXTO

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.64
Price
kr79.40
GF Value